Company Registration No. 15403120 (England and Wales)
CRESCENT PHARMACY LIMITED
ACCOUNTS
FOR THE PERIOD ENDED
31 JANUARY 2025
31 January 2025
CRESCENT PHARMACY LIMITED                        COMPANY NO: 15403120
STATEMENT OF FINANCIAL POSITION                            (ENGLAND AND WALES)
AS AT 31 JANUARY 2025
2025
£
Assets
Cash
200
Net assets
200
Represented by:
Share capital, issued and fully paid
100 Ordinary A Shares of £1 each
100
100 Ordinary B Shares of £1 each
100
200
The average number of persons, including directors, employed by the company during the period was as follows:
2025
Number
Employees
1
Statements:
Crescent Pharmacy Limited is a private company limited by shares incorporated in England and Wales. The
registered office is 1st Floor, 3 Hobbs House, Harrovian Business Village, Bessborough Road, Harrow, HA1 3EX.
These accounts have been prepared in accordance with the provisions applicable to small companies within Part 15 of the Companies Act 2006.
For the financial period ended 31 January 2025, the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 (as a dormant company).
The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of the accounts.
During the period, 100 ordinary A shares of £1 each and 100 ordinary B shares of £1 each were allotted and fully paid at par for cash consideration.
These accounts were approved by the Board of Directors on
September 22, 2025.
22 September 2025
MR N VALJI……………………………………….
DIRECTOR
Company Registration No. 15403120
trueCCH SoftwareiXBRL Review & Tag 2025.22025-01-312024-01-10false154031202024-01-102025-01-3115403120bus:Micro-entities2024-01-102025-01-31154031202025-01-3115403120bus:PrivateLimitedCompanyLtd2024-01-102025-01-3115403120bus:EntityHasNeverTraded2024-01-102025-01-3115403120bus:AuditExempt-NoAccountantsReport2024-01-102025-01-3115403120bus:FullAccounts2024-01-102025-01-31xbrli:purexbrli:sharesiso4217:GBP